Literature DB >> 10665816

The contributions of GluR2 to allosteric modulation of AMPA receptors.

J L Cotton1, K M Partin.   

Abstract

Native AMPA receptor complexes in the CNS are composed of hetero-oligomers of the GluR1-4 subunits, and generally contain the GluR2 subunit. To determine the contributions of GluR2 to pharmacological properties of receptor complexes, the effect of hetero-oligomerization with GluR2 on allosteric modulation of recombinant AMPA receptors was studied. The study of homo-oligomeric GluR2 was facilitated with a site-directed mutant of the pore, GluR2(R607Q), which allowed robust currents from this normally low-conducting subunit. The efficacy of the allosteric modulators was tested on homo-oligomeric GluR1-4, and then compared with hetero-oligomeric GluR1/GluR2, GluR3/GluR2 and GluR4/GluR2. Two selective allosteric modulators were tested, a positive modulator, cyclothiazide, and a negative modulator, LY300164. The results show that the pharmacological properties of homo-oligomeric GluR2 are not significantly different from those of GluR1, GluR3 or GluR4. The apparent affinity of cyclothiazide is not significantly changed upon hetero-oligomerization. However, the extent of potentiation of kainate responses by cyclothiazide is significantly decreased upon hetero-oligomerization. Hetero-oligomerization increases the apparent affinity of LY300164, a (-) isomer of the 2,3-benzodiazepine LY293606. These data indicate that although GluR2 has a dominant effect on the permeation properties, this subunit does not have a similarly dominant effect on pharmacological properties of native receptors. However, the state of hetero-oligomerization can alter the pharmacological properties of AMPA receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10665816     DOI: 10.1016/s0028-3908(99)00105-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Domain interactions regulating ampa receptor desensitization.

Authors:  K M Partin
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

Review 2.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  AMPA receptors associated with zebrafish Mauthner cells switch subunits during development.

Authors:  Shunmoogum Aroonassala Patten; Declan W Ali
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

4.  The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice.

Authors:  K Iihara; D T Joo; J Henderson; R Sattler; F A Taverna; S Lourensen; B A Orser; J C Roder; M Tymianski
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

5.  Activity-dependent change in AMPA receptor properties in cerebellar stellate cells.

Authors:  Siqiong June Liu; Stuart G Cull-Candy
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

6.  Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation.

Authors:  David E Timm; Morris Benveniste; Autumn M Weeks; Eric S Nisenbaum; Kathryn M Partin
Journal:  Mol Pharmacol       Date:  2011-05-04       Impact factor: 4.436

Review 7.  Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death.

Authors:  R Sattler; M Tymianski
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

8.  Affecting AMPA Receptor Biophysical Gating Properties with Negative Allosteric Modulators.

Authors:  Mohammad Qneibi; Mohammad Hawash; Nidal Jaradat; Sosana Bdir
Journal:  Mol Neurobiol       Date:  2022-06-10       Impact factor: 5.682

9.  Effects of cyclothiazide on GluR1/AMPA receptors.

Authors:  Sergio Fucile; Ricardo Miledi; Fabrizio Eusebi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.